Morgan Stanley’s KALA BIO KALA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.63K Hold
972
﹤0.01% 7057
2025
Q1
$5.57K Hold
972
﹤0.01% 6963
2024
Q4
$6.75K Sell
972
-23
-2% -$160 ﹤0.01% 6924
2024
Q3
$5.67K Sell
995
-20
-2% -$114 ﹤0.01% 6877
2024
Q2
$7.2K Sell
1,015
-346
-25% -$2.45K ﹤0.01% 6767
2024
Q1
$10.8K Sell
1,361
-1,881
-58% -$15K ﹤0.01% 6671
2023
Q4
$22.7K Buy
3,242
+1,589
+96% +$11.1K ﹤0.01% 6619
2023
Q3
$14.7K Hold
1,653
﹤0.01% 6580
2023
Q2
$24.1K Buy
1,653
+95
+6% +$1.39K ﹤0.01% 6504
2023
Q1
$23.4K Sell
1,558
-536
-26% -$8.07K ﹤0.01% 6567
2022
Q4
$79.9K Buy
2,094
+28
+1% +$1.07K ﹤0.01% 6082
2022
Q3
$23K Sell
2,066
-408
-16% -$4.54K ﹤0.01% 6732
2022
Q2
$37K Sell
2,474
-583
-19% -$8.72K ﹤0.01% 6746
2022
Q1
$210K Sell
3,057
-1,227
-29% -$84.3K ﹤0.01% 5893
2021
Q4
$260K Sell
4,284
-1,850
-30% -$112K ﹤0.01% 5925
2021
Q3
$802K Buy
6,134
+1,678
+38% +$219K ﹤0.01% 5193
2021
Q2
$1.18M Buy
4,456
+2,315
+108% +$613K ﹤0.01% 4983
2021
Q1
$721K Sell
2,141
-651
-23% -$219K ﹤0.01% 4938
2020
Q4
$946K Buy
2,792
+1,130
+68% +$383K ﹤0.01% 4701
2020
Q3
$622K Buy
1,662
+309
+23% +$116K ﹤0.01% 4531
2020
Q2
$711K Buy
1,353
+1,228
+982% +$645K ﹤0.01% 4404
2020
Q1
$55K Sell
125
-474
-79% -$209K ﹤0.01% 5431
2019
Q4
$110K Buy
599
+462
+337% +$84.8K ﹤0.01% 5626
2019
Q3
$26K Buy
137
+110
+407% +$20.9K ﹤0.01% 5936
2019
Q2
$8K Sell
27
-62
-70% -$18.4K ﹤0.01% 6190
2019
Q1
$37K Sell
89
-483
-84% -$201K ﹤0.01% 5795
2018
Q4
$139K Buy
572
+187
+49% +$45.4K ﹤0.01% 5428
2018
Q3
$190K Sell
385
-223
-37% -$110K ﹤0.01% 5479
2018
Q2
$417K Sell
608
-33
-5% -$22.6K ﹤0.01% 5215
2018
Q1
$507K Buy
641
+321
+100% +$254K ﹤0.01% 4996
2017
Q4
$295K Buy
320
+110
+52% +$101K ﹤0.01% 5261
2017
Q3
$239K Buy
+210
New +$239K ﹤0.01% 5263